ストックスクリーナーアプリを入手
10.05
28.52%
2.23
アフターアワーズ：
16.34
6.29
+62.59%
前日終値:
$7.82
開ける：
$7.9
24時間の取引高:
6.51M
Relative Volume:
1.63
時価総額：
$717.15M
収益：
-
当期純損益:
$-192.96M
株価収益率:
-3.0455
EPS:
-3.3
ネットキャッシュフロー:
$-167.04M
1週間 パフォーマンス:
+14.86%
1か月 パフォーマンス:
+15.25%
6か月 パフォーマンス:
+383.17%
1年 パフォーマンス:
+315.29%
1日の値動き範囲:
$7.08
$25.00
1週間の範囲:
$7.08
$25.00
52週間の値動き範囲:
$0.783
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
名前
Ventyx Biosciences Inc
セクター
電話
(760) 407-6511
住所
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
VTYX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
10.05 | 558.02M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-05 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-03-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-11-07 | ダウングレード | Stifel | Buy → Hold |
| 2023-11-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-03-21 | 開始されました | Wells Fargo | Overweight |
| 2022-12-19 | 開始されました | Goldman | Buy |
| 2022-11-17 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-07 | 開始されました | Stifel | Buy |
| 2022-09-01 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-09 | 開始されました | Credit Suisse | Outperform |
| 2022-03-31 | 開始されました | Canaccord Genuity | Buy |
| 2022-02-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-15 | 開始されました | Jefferies | Buy |
| 2021-11-15 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Ventyx Biosciences Inc (VTYX) 最新ニュース
Ventyx Biosciences Stock Pre-Market (+63%) : Unconfirmed LLY Takeover Rumors - Trefis
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock - Benzinga
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock - Benzinga
Sandisk, Alumis, Micron Technology, Ventyx Biosciences, And Western Digital: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Ventyx Biosciences Jumps 62% On Reported $1 Bln Acquisition Talks With Eli Lilly - Nasdaq
Report: Eli Lilly eyeing $1B-takeout of Ventyx - FirstWord
Ventyx Biosciences stock surges after Eli Lilly acquisition talks - Investing.com
Ventyx BiosciencVentyx Biosciences Stock Jumps 56% After Hours On Reports Of $1 Billion Eli Lilly Buyout - Stocktwits
Eli Lilly stock rises after hours on Nimbus obesity pill deal as Ventyx talks surface - ts2.tech
Ventyx Biosciences jumps on report Eli Lilly nears more than $1B deal - MSN
Lilly in talks to buy Ventyx Biosciences for more than $1 billion, WSJ reports - The Mighty 790 KFGO
Small Biotech Launches On Rumored $1 Billion Eli Lilly Buyout - Investor's Business Daily
After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis By Investing.com - Investing.com Nigeria
After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis - Investing.com
Eli Lilly Is Closing In on Deal With Biotech Ventyx, WSJ Says - Bloomberg.com
Lilly's Billion-Dollar Bet on Inflammation: Why the Ventyx Deal Is About 2030, Not Tomorrow - CTOL Digital Solutions
Eli Lilly (LLY) Nears Acquisition Deal with Ventyx Valued Over $1 Billion - GuruFocus
Eli Lilly said to be close to buying Ventyx for over $1B - breakingthenews.net
Ventyx Biosciences stock surges after Eli Lilly acquisition talks By Investing.com - Investing.com Nigeria
Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports By Reuters - Investing.com
Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports - marketscreener.com
Exclusive | Eli Lilly Nears Deal for Biotech Ventyx - The Wall Street Journal
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - GlobeNewswire Inc.
Ventyx Stock Jumps After Report of Eli Lilly Takeover Talks - The Wall Street Journal
Ventyx Biosciences (NASDAQ:VTYX) Shares Down 6.1%Time to Sell? - MarketBeat
Investors Purchase Large Volume of Call Options on Ventyx Biosciences (NASDAQ:VTYX) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Ventyx Biosciences, Inc. (VTYX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc.VTYX - PR Newswire
Ventyx Biosciences (NASDAQ:VTYX) Trading Up 2.8%Here's What Happened - MarketBeat
Ventyx Biosciences (NASDAQ:VTYX) Shares Down 3.4%Time to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ventyx Biosciences, Inc. (VTYX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Will Ventyx Biosciences Inc. stock benefit from green energy trendsBollinger Bands Signals & Affordable Market Insights - bollywoodhelpline.com
Bronstein, Gewirtz & Grossman, LLC Encourages Ventyx Biosciences, Inc. (VTYX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ventyx Biosciences, Inc. (VTYX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Ventyx Biosciences, Inc. (VTYX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ventyx Biosciences, Inc. (VTYX) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ventyx Biosciences, Inc. (VTYX) And Encourages Stockholders to Reach Out - ACCESS Newswire
Will Ventyx Biosciences Inc. stock return to pre crisis levelsMarket Sentiment Summary & Free Fast Entry Momentum Trade Alerts - Улправда
Ventyx Biosciences, Inc.(NasdaqGS:VTYX) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ventyx Biosciences, Inc. (VTYX) And Encourages Stockholders to Connect - ACCESS Newswire
One Ventyx Biosciences Insider Raised Their Stake In The Previous Year - Yahoo Finance
Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives - Insider Monkey
VTYX DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Ventyx Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 30 Deadline in Securities Class Action – VTYX - Macau Business
Will Ventyx Biosciences Inc. stock split attract more investorsWeekly Risk Summary & Free Fast Gain Swing Trade Alerts - bolumsonucanavari.com
Is Ventyx Biosciences Inc. stock a safe haven assetJuly 2025 Spike Watch & Low Volatility Stock Suggestions - Улправда
Ventyx Biosciences (NASDAQ:VTYX) Insider John Nuss Sells 12,675 Shares - MarketBeat
Insider Selling: Ventyx Biosciences (NASDAQ:VTYX) CEO Sells 47,345 Shares of Stock - MarketBeat
Ventyx Biosciences Executives Conduct Share Transactions - TradingView — Track All Markets
Ventyx Biosciences (NASDAQ:VTYX) Trading 13.5% HigherStill a Buy? - MarketBeat
Ventyx Biosciences Inc (VTYX) 財務データ
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):